Abstract:In the COVID pandemic era, increased mortality was seen despite some unknown etiologies other than SARS-CoV2 viral infection. Vaccination targeted to SARS-CoV2 was successful due to infection caused by pathogens of viral origin based on symptomatology. Hence, it is essential to detect other viral and bacterial infections throughout the initial wave of the COVID-19 disease outbreak, particularly in those suffering from a symptomatic respiratory infection with SARS-CoV-2-negative status. This study was planned to explore the presence of bacterial and other respiratory viruses in symptomatic patients with SARS-CoV2-positive or negative status. The study selected128 patient’s samples out of 200 patients’ samples (100 at each time point) collected for routine SARS-CoV-2 detection schedule in December 2020 and June 2021. Considering the seasonal changes responsible for the occurrence of respiratory pathogens, we finalized 64 SARS-CoV-2 tested patients with 32 SARS-CoV-2-negatives and 32 SARS-CoV-2-positives from each collection time to examine them further using real-time PCR for the presence of other viral species and bacterial infection analyzing 16S rRNA metagenome supporting to cause respiratory infections. Along with various symptoms, we observed the co-infection of adenovirus and influenza B(Victoria) virus to two SARS-CoV-2-positive samples. The SARS-CoV-2-negative but symptomatic patient showed Rhinovirus (7/64 i.e. 10.9%) and Influenza (A/H3N2) infection in 4 patients out of 64 patients (6.25%). Additionally, one SARS-CoV-2-negative patient enrolled in June 2021 showed PIV-3 infection. Influenza A/H3N2 and Adenovirus were the cause of symptoms in SARS-CoV-2-negative samples significantly. Thus, the overall viral infections are considerably higher among SARS-CoV-2-negative patients (37.5% Vs 6.25%) compared to SARS-CoV-2-positive patients representing respiratory illness probably due to the abundance of the viral entity as well as competition benefit of SARS-CoV-2 in altering the imperviousness of the host. Simultaneously, 16S rRNA ribosomal RNA metagenomenext-generation sequencing (NGS) data from the same set of samples indicated a higher frequency of Firmicutes, Proteobacteria, Bacteroidota, Actinobacteriota, fusobacteriota, Patescibacteria, and Campilobacterotaphyla out of 15 phyla, 240 species from positive and 16 phyla, 274 species from negative samples. Exploring co-infecting respiratory viruses and bacterial populations becomes significant in understanding the mechanisms associated with multiple infecting pathogens from symptomatic COVID-positive and negative individuals for initiating proper antimicrobial therapy.

Bacterial microbiota in upper respiratory tract of COVID-19 and influenza patients

A case report demonstrating the utility of next generation sequencing in analyzing serial samples from the lung following an infection with influenza A (H7N9) virus.

16S Rdna Sequencing Analysis of Upper Respiratory Tract Flora in Patients with Influenza H1N1 Virus Infection

Perturbations in gut and respiratory microbiota in COVID-19 and influenza patients: a systematic review and meta-analysis

Comparison of microbial composition and diversity in the upper respiratory tract between SARS-CoV-2 and influenza virus infections

Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Fatality in COVID-19 Patients

The characteristics of microbiome in the upper respiratory tract of COVID-19 patients

Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza.

Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19

Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection

Detection of bacterial co-infection in patients with severe influenza

Effect of <i>SARS-CoV-2</i> Infection on the Microbial Composition of Upper Airway

The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens

Comparison of the respiratory tract microbiome in hospitalized COVID‐19 patients with different disease severity

Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection

Distinct Nasopharyngeal and Oropharyngeal Microbiota of Children with Influenza A Virus Compared with Healthy Children

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults

Analysis of Lung Microbiome in COVID-19 Patients during Time of Hospitalization

Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance

Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID‐19 and its Association with Microbiota in the Gut

Exploring respiratory viral pathogens and bacteriome from symptomatic SARS-CoV-2-negative and positive individuals